ETNB
Price
$9.86
Change
-$0.09 (-0.90%)
Updated
Jun 27 closing price
Capitalization
1.44B
39 days until earnings call
SLS
Price
$1.95
Change
-$0.08 (-3.94%)
Updated
Jun 27 closing price
Capitalization
194.57M
39 days until earnings call
Interact to see
Advertisement

ETNB vs SLS

Header iconETNB vs SLS Comparison
Open Charts ETNB vs SLSBanner chart's image
89bio
Price$9.86
Change-$0.09 (-0.90%)
Volume$3.98M
Capitalization1.44B
SELLAS Life Sciences Group
Price$1.95
Change-$0.08 (-3.94%)
Volume$15.9M
Capitalization194.57M
ETNB vs SLS Comparison Chart in %
Loading...
ETNB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ETNB vs. SLS commentary
Jun 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ETNB is a Buy and SLS is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 29, 2025
Stock price -- (ETNB: $9.86 vs. SLS: $1.95)
Brand notoriety: ETNB and SLS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ETNB: 198% vs. SLS: 533%
Market capitalization -- ETNB: $1.44B vs. SLS: $194.57M
ETNB [@Biotechnology] is valued at $1.44B. SLS’s [@Biotechnology] market capitalization is $194.57M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ETNB’s FA Score shows that 1 FA rating(s) are green whileSLS’s FA Score has 0 green FA rating(s).

  • ETNB’s FA Score: 1 green, 4 red.
  • SLS’s FA Score: 0 green, 5 red.
According to our system of comparison, ETNB is a better buy in the long-term than SLS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ETNB’s TA Score shows that 4 TA indicator(s) are bullish while SLS’s TA Score has 5 bullish TA indicator(s).

  • ETNB’s TA Score: 4 bullish, 4 bearish.
  • SLS’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, SLS is a better buy in the short-term than ETNB.

Price Growth

ETNB (@Biotechnology) experienced а -2.18% price change this week, while SLS (@Biotechnology) price change was +26.62% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

ETNB is expected to report earnings on Aug 07, 2025.

SLS is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ETNB($1.44B) has a higher market cap than SLS($195M). SLS YTD gains are higher at: 87.500 vs. ETNB (26.087). SLS has higher annual earnings (EBITDA): -27.93M vs. ETNB (-380.21M). ETNB has more cash in the bank: 639M vs. SLS (28.4M). SLS has less debt than ETNB: SLS (870K) vs ETNB (37.6M). ETNB (0) and SLS (0) have equivalent revenues.
ETNBSLSETNB / SLS
Capitalization1.44B195M737%
EBITDA-380.21M-27.93M1,361%
Gain YTD26.08787.50030%
P/E RatioN/AN/A-
Revenue00-
Total Cash639M28.4M2,250%
Total Debt37.6M870K4,322%
FUNDAMENTALS RATINGS
SLS: Fundamental Ratings
SLS
OUTLOOK RATING
1..100
59
VALUATION
overvalued / fair valued / undervalued
1..100
59
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
36
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ETNBSLS
RSI
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bullish Trend 3 days ago
85%
Bullish Trend 3 days ago
89%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
85%
Bullish Trend 3 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 3 days ago
83%
Advances
ODDS (%)
Bullish Trend 10 days ago
86%
Bullish Trend 4 days ago
86%
Declines
ODDS (%)
Bearish Trend 13 days ago
86%
Bearish Trend 13 days ago
86%
BollingerBands
ODDS (%)
N/A
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
85%
Bullish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ETNB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SPFFX29.030.17
+0.59%
Sphere 500 Climate Fund
LEICX22.690.11
+0.49%
Federated Hermes Equity Income C
CBALX53.610.18
+0.34%
Columbia Balanced Inst
PCSMX15.060.02
+0.13%
Principal SmallCap Growth I R6
JSJFX16.43-0.01
-0.06%
JHancock Small Cap Dynamic Growth R6

ETNB and

Correlation & Price change

A.I.dvisor indicates that over the last year, ETNB has been loosely correlated with AKRO. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if ETNB jumps, then AKRO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ETNB
1D Price
Change %
ETNB100%
-0.90%
AKRO - ETNB
60%
Loosely correlated
-0.16%
IDYA - ETNB
53%
Loosely correlated
-4.13%
DNLI - ETNB
53%
Loosely correlated
-2.69%
CRNX - ETNB
50%
Loosely correlated
-0.10%
SNDX - ETNB
50%
Loosely correlated
-2.80%
More

SLS and

Correlation & Price change

A.I.dvisor indicates that over the last year, SLS has been loosely correlated with AKRO. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if SLS jumps, then AKRO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLS
1D Price
Change %
SLS100%
-3.94%
AKRO - SLS
43%
Loosely correlated
-0.16%
ARGNF - SLS
36%
Loosely correlated
N/A
SABS - SLS
31%
Poorly correlated
-5.06%
ETNB - SLS
27%
Poorly correlated
-0.90%
LPTX - SLS
26%
Poorly correlated
-6.47%
More